[Federal Register Volume 75, Number 74 (Monday, April 19, 2010)]
[Notices]
[Page 20370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-8984]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Assay Systems for Drug Efficacy in Cancer Stem Cells.
    Date: April 28, 2010.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 6006, Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Kirt Vener, PhD, Branch Chief, Special Review 
and Logistics Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 6116 Executive Blvd., Room 8061, Bethesda, MD 
20892-8329, 301-496-7174, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Breast Cancer Biology.
    Date: May 20, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review 
Officer, National Cancer Institute, National Institutes of Health, 
6116 Executive Blvd., Room 8050A, MSC 8329, Bethesda, MD 20852, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Molecular Oncology--Basic, Translational and Clinical 
Studies.
    Date: May 25-26, 2010
    Time: 7:30 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: David G. Ransom, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 8133, 
Bethesda, MD 20892-8328, 301-451-4757, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-8984 Filed 4-16-10; 8:45 am]
BILLING CODE 4140-01-P